ZA908775B - Pharmaceutical compositions and methods for treating the symptoms of overindulgence - Google Patents
Pharmaceutical compositions and methods for treating the symptoms of overindulgenceInfo
- Publication number
- ZA908775B ZA908775B ZA908775A ZA908775A ZA908775B ZA 908775 B ZA908775 B ZA 908775B ZA 908775 A ZA908775 A ZA 908775A ZA 908775 A ZA908775 A ZA 908775A ZA 908775 B ZA908775 B ZA 908775B
- Authority
- ZA
- South Africa
- Prior art keywords
- overindulgence
- symptoms
- treating
- methods
- pharmaceutical compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 208000024891 symptom Diseases 0.000 title abstract 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract 2
- 229940122957 Histamine H2 receptor antagonist Drugs 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 210000004211 gastric acid Anatomy 0.000 abstract 1
- 239000000938 histamine H1 antagonist Substances 0.000 abstract 1
- 239000003485 histamine H2 receptor antagonist Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 1
- 229960005489 paracetamol Drugs 0.000 abstract 1
- 229940126409 proton pump inhibitor Drugs 0.000 abstract 1
- 239000000612 proton pump inhibitor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43083789A | 1989-11-02 | 1989-11-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA908775B true ZA908775B (en) | 1992-07-29 |
Family
ID=23709269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA908775A ZA908775B (en) | 1989-11-02 | 1990-11-01 | Pharmaceutical compositions and methods for treating the symptoms of overindulgence |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0426479B1 (enExample) |
| JP (1) | JPH03206052A (enExample) |
| KR (1) | KR910009254A (enExample) |
| AT (1) | ATE101515T1 (enExample) |
| AU (1) | AU646230B2 (enExample) |
| CA (1) | CA2028746C (enExample) |
| DE (1) | DE69006684T2 (enExample) |
| ES (1) | ES2057439T3 (enExample) |
| GR (1) | GR1002097B (enExample) |
| IE (1) | IE64953B1 (enExample) |
| IN (1) | IN171746B (enExample) |
| NZ (1) | NZ235877A (enExample) |
| PT (1) | PT95753A (enExample) |
| ZA (1) | ZA908775B (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0550083T3 (da) * | 1991-12-06 | 1999-10-11 | Glaxo Group Ltd | Lægemidler til behandling af inflammatoriske tilstande eller til analgesi og indeholdende et NSAID og ranitidinbismuthcitra |
| CA2144155A1 (en) * | 1992-09-29 | 1994-04-14 | Robert T. Sims | Ibuprofen-h2 antagonist combinations |
| GB9221414D0 (en) * | 1992-10-13 | 1992-11-25 | Glaxo Group Ltd | Pharmaceutical compositions |
| US5648355A (en) * | 1994-02-09 | 1997-07-15 | Kos Pharmaceutical, Inc. | Method of treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin |
| SE9600072D0 (sv) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients II |
| SE9600070D0 (sv) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
| ZA975444B (en) * | 1996-06-20 | 1998-12-21 | Mcneil Ppc Inc | Acetaminophen and meclizine hydrochloride analgesics |
| WO1998058637A1 (en) * | 1996-06-20 | 1998-12-30 | Mcneil-Ppc | Acetaminophen and diphenhydramine analgesics |
| DE19801811B4 (de) * | 1998-01-19 | 2004-12-23 | Stada Arzneimittel Ag | Pharmazeutische Zubereitung zur oralen Verabreichung |
| US7799766B2 (en) | 1998-04-08 | 2010-09-21 | Theta Biomedical Consulting & Development Co., Inc. | Composition for treating hormonally-dependent cancers |
| US7906153B2 (en) | 1998-04-08 | 2011-03-15 | Theta Biomedical Consulting & Development Co., Inc. | Anti-inflammatory compositions for treating multiple sclerosis |
| US20050220909A1 (en) | 2004-03-30 | 2005-10-06 | Theoharides Theoharis C | Composition for protection against superficial vasodilator flush syndrome |
| GB9911017D0 (en) * | 1999-05-13 | 1999-07-14 | Zeneca Ltd | Pharmaceutical compositions |
| IL145220A0 (en) * | 1999-05-20 | 2002-06-30 | Par Pharmaceutical Inc | Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process |
| AU4973800A (en) * | 1999-06-09 | 2000-12-28 | Eli Lilly And Company | Combination for treating weight gain associated with antipsychotic use comprising an atypical antipsychotic and an h2 antagonist |
| SE0000774D0 (sv) | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
| CZ20032398A3 (cs) * | 2001-03-08 | 2004-02-18 | Astrazeneca Ab | Nové použití derivátů 6-karboxamidoimidazo [1,2-a] pyridinu |
| US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
| DK1411900T4 (da) | 2001-06-01 | 2014-01-27 | Pozen Inc | Farmaceutiske sammensætninger til den koordinerede frigørelse af NSAIDs |
| SE0102993D0 (sv) | 2001-09-07 | 2001-09-07 | Astrazeneca Ab | New self emulsifying drug delivery system |
| US20040121004A1 (en) * | 2002-12-20 | 2004-06-24 | Rajneesh Taneja | Dosage forms containing a PPI, NSAID, and buffer |
| US20040185032A1 (en) * | 2003-03-18 | 2004-09-23 | David Burrell | Compositions and methods for treating colic |
| US7923043B2 (en) | 2004-03-30 | 2011-04-12 | Theta Biomedical Consulting & Development Co., Inc. | Method for protecting humans against superficial vasodilator flush syndrome |
| US7776873B2 (en) * | 2005-12-01 | 2010-08-17 | Yuhan Corporation | Method for treating damage to gastric mucosa |
| EP3090739A1 (en) * | 2008-01-04 | 2016-11-09 | Schabar Research Associates LLC | Compositions composed of naproxen sodium and nizatidine |
| KR20110079641A (ko) | 2008-09-09 | 2011-07-07 | 아스트라제네카 아베 | 제약 조성물을 이를 필요로 하는 환자에게 전달하는 방법 |
| MX2011013467A (es) | 2009-06-25 | 2012-02-13 | Astrazeneca Ab | Metodo para tratar un paciente que corre el riesgo de desarollar una ulcera asociada a antiinflamatorio no esteroide (aine). |
| US9176146B2 (en) | 2009-08-03 | 2015-11-03 | Theta Biomedical Consulting & Development Co., Inc. | Methods of treating autism spectrum disorders and compositions for same |
| US9050275B2 (en) | 2009-08-03 | 2015-06-09 | Theta Biomedical Consulting & Development Co., Inc. | Methods of screening for and treating autism spectrum disorders and compositions for same |
| US9539214B2 (en) | 2011-12-28 | 2017-01-10 | Pozen Inc. | Compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
| US11324727B2 (en) | 2020-07-15 | 2022-05-10 | Schabar Research Associates, Llc | Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn |
| JP2023534810A (ja) | 2020-07-15 | 2023-08-14 | シャバー リサーチ アソシエイツ エルエルシー | 急性痛の処置並びに胸やけの重症度及び／又はリスクの低減のための、イブプロフェン及びファモチジンから構成される単位経口用量組成物 |
| US12514846B2 (en) | 2020-07-15 | 2026-01-06 | Schabar Research Associates Llc | Unit oral dose compositions composed of ibuprofen or a pharmaceutically acceptable salt thereof and famotidine or a pharmaceutically acceptable salt thereof for the treatment of acute pain and the reduction of the severity and/or risk of heartburn and/or upset stomach |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2105193B (en) * | 1981-09-04 | 1984-09-12 | Glaxo Group Ltd | Pharmaceutical compositions containing non-steroidal anti-inflammatory agents |
| US4522826A (en) * | 1984-02-08 | 1985-06-11 | Richardson-Vicks Inc. | Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same |
| US4757060A (en) * | 1986-03-04 | 1988-07-12 | Bristol-Myers Company | Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers |
-
1990
- 1990-10-29 IN IN907/CAL/90A patent/IN171746B/en unknown
- 1990-10-29 NZ NZ235877A patent/NZ235877A/xx unknown
- 1990-10-31 PT PT95753A patent/PT95753A/pt not_active Application Discontinuation
- 1990-10-31 AU AU65689/90A patent/AU646230B2/en not_active Ceased
- 1990-10-31 CA CA002028746A patent/CA2028746C/en not_active Expired - Lifetime
- 1990-11-01 EP EP90311995A patent/EP0426479B1/en not_active Revoked
- 1990-11-01 DE DE69006684T patent/DE69006684T2/de not_active Revoked
- 1990-11-01 ES ES90311995T patent/ES2057439T3/es not_active Expired - Lifetime
- 1990-11-01 AT AT90311995T patent/ATE101515T1/de not_active IP Right Cessation
- 1990-11-01 IE IE394690A patent/IE64953B1/en not_active IP Right Cessation
- 1990-11-01 ZA ZA908775A patent/ZA908775B/xx unknown
- 1990-11-01 KR KR1019900017661A patent/KR910009254A/ko not_active Ceased
- 1990-11-01 GR GR900100786A patent/GR1002097B/el not_active IP Right Cessation
- 1990-11-02 JP JP2298713A patent/JPH03206052A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IN171746B (enExample) | 1992-12-26 |
| KR910009254A (ko) | 1991-06-28 |
| GR900100786A (el) | 1992-04-17 |
| EP0426479B1 (en) | 1994-02-16 |
| ATE101515T1 (de) | 1994-03-15 |
| AU6568990A (en) | 1991-05-09 |
| IE64953B1 (en) | 1995-09-20 |
| NZ235877A (en) | 1992-09-25 |
| CA2028746A1 (en) | 1991-05-03 |
| JPH03206052A (ja) | 1991-09-09 |
| IE903946A1 (en) | 1991-05-08 |
| AU646230B2 (en) | 1994-02-17 |
| PT95753A (pt) | 1991-09-30 |
| DE69006684D1 (de) | 1994-03-24 |
| CA2028746C (en) | 1995-12-26 |
| DE69006684T2 (de) | 1994-06-09 |
| GR1002097B (en) | 1995-12-28 |
| EP0426479A1 (en) | 1991-05-08 |
| ES2057439T3 (es) | 1994-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU646230B2 (en) | Pharmaceutical compositions and methods for treating the symptoms of overindulgence | |
| BR9814327A (pt) | Compostos de tiouréia e benzamida, composições e pro-cessos para tratamento ou prevenção de doenças infla-matórias e arteriosclerose | |
| IL93556A0 (en) | Stabilized nitric oxide-primary amine complexes useful as cardiovascular agents | |
| FI944712A7 (fi) | Suun kautta annettavia opioidisia kestovaikutteisia formulaatioita | |
| BR9806060A (pt) | Composto, composição farmacêutica e processos para tratar um paciente sofrendo de um estado doentio, para inibir o fator xa, e, para inibir a formação de trombina. | |
| NL300152I1 (nl) | Preparaat dat een tramadolverbinding en aceetaminofen bevat. | |
| PH31378A (en) | Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug. | |
| NO180583C (no) | Arylsulfonamido-substituerte hydroksamsyrer, farmasöytiske preparater inneholdende forbindelsene og anvendelse av forbindelsene for fremstilling av farmasöytiske preparater | |
| WO1992019617A3 (en) | Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use | |
| AP9701041A0 (en) | Pyridylpyrrole compounds. | |
| IL165816A0 (en) | Use of cyclooxygenase-2 inhibitors for the manufacture of a medicament for the treatment and prevention of neoplasia | |
| UA26403A (uk) | Похідhі n-заміщеhого 4-феhіл-4-піперидиhкарбоксаміду та їх фармацевтичhо прийhятhі солі, що проявляють аhестезувальhу та аhальгезувальhу дію, спосіб їх одержаhhя та фармацевтичhа композиція | |
| PT1057826E (pt) | Derivados carboxamidicos dimericos substituidos processo para a sua preparacao e as composicoes farmaceuticas que os contem | |
| NO954073D0 (no) | Sammensetninger for inhibisjon, kontroll og regresjon av angiogenesen inneholdende hyaluronsyre og NSAID | |
| DK0613687T3 (da) | Anvendelse af pregnanderivat til behandling af tumorer | |
| IL159241A0 (en) | Use of branched-chain fatty acids and derivatives thereof for the treatment of pain | |
| WO2001003688A3 (en) | Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds | |
| HU229440B1 (en) | Analgesic and anti-inflammatory compositions containing gox-2 inhibitors | |
| AU8900498A (en) | Compounds and pharmaceutical compositions thereof for eliciting analgesic effects | |
| PL318539A1 (en) | Inhibition of biosynthesis | |
| ZA989356B (en) | Pharmaceutical preparations | |
| ES8301230A1 (es) | Un procedimiento para la preparacion de 1-fenil-5-amidotetrazoles. | |
| SE8504612D0 (sv) | Analgetiska och antiinflammatoriska kompositioner innefattande difenhydramin och forfaranden for anvendning av dessa | |
| IT8422445A0 (it) | Composti antiinfiammatori ed analgesici, procedimento per laloro preparazione e relative composizioni farmaceutiche. | |
| MX9703610A (es) | Nuevas (5,6)-heteroaril condensado-pirimidin-4-onas 2,3 disustituidas. |